Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.

Acta neuropathologica - 1 Oct 2016

Tabouret Emeline, Nguyen Anh Tuan, Dehais Caroline, Carpentier Catherine, Ducray François, Idbaih Ahmed, Mokhtari Karima, Jouvet Anne, Uro-Coste Emmanuelle, Colin Carole, Chinot Olivier, Loiseau Hugues, Moyal Elisabeth, Maurage Claude-Alain, Polivka Marc, Lechapt-Zalcman Emmanuèle, Desenclos Christine, Meyronet David, Delattre Jean-Yves, Figarella-Branger Dominique

Abstract excerpt

The new WHO classification of diffuse gliomas has been refined and now includes the 1p/19q codeletion, IDH1/2 mutation, and histone H3-K27M mutation. Our objective was to assess the prognostic value of the updated 2016 WHO classification in the French POLA cohort. All cases of high-grade oligodendroglial tumors sent for central pathological review and included into the French nationwide POLA cohort were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Disease-Free Survival

Share to Glioma

Share to Oligodendroglioma

Share to Prognosis

Share to World Health Organization

Source

Identifiers

PMID: 27573687
DOI: 10.1007/s00401-016-1611-8

Genes

IDH1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.PMID 27573687Read ↗

Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.Semantic proximity Read ↗

The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.Semantic proximity Read ↗

Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.Semantic proximity Read ↗

A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted.Semantic proximity Read ↗

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnosticsSemantic proximity Read ↗

Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System.Semantic proximity Read ↗

[Update on the 2016 WHO classification of tumors of the central nervous system - Part 1: Diffusely infiltrating gliomas].Semantic proximity Read ↗

Adult type diffuse gliomas in the new 2021 WHO Classification.Semantic proximity Read ↗

Molecular classification of low-grade diffuse gliomas.Semantic proximity Read ↗

Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.Semantic proximity Read ↗

Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management.Semantic proximity Read ↗

[World Health Organization Classification of Central Nervous System Tumours, 5th Edition:Points of the Update and the Current Status].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.